Bank of Montreal’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bank of Montreal’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-74,000	Closed	-$95K	–	4538
2017 Q4	$95K	Hold	74,000	–	–	﹤0.01%	3022
2017 Q3	$157K	Buy	74,000 +5,500	+8%	+$13.4K	﹤0.01%	2764
2017 Q2	$199K	Sell	68,500 -20,000	-23%	-$60K	﹤0.01%	2655
2017 Q1	$304K	Buy	+88,500	New	+$349K	﹤0.01%	2289
2014 Q4	–	Sell	-5,000	Closed	-$213K	–	4394
2014 Q3	$213K	Buy	5,000 +3,850	+335%	+$207K	﹤0.01%	2509
2014 Q2	$71K	Buy	+1,150	New	+$66.9K	﹤0.01%	3040

Other funds holding OREX

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OWIM

Old West Investment Management Los Angeles, California $944M AUM 90.26% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of Montreal's OREX Position: Q1 2018 in Review

Bank of Montreal sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2018, closing a stake of 74,100 shares — an estimated $95K sold.

Bank of Montreal first reported a position in OREX in Q2 2013 and held it in 12 quarters. The position peaked at $304K in Q1 2017. 27 funds tracked by Wall St. Rank hold OREX as of Q1 2018.

Bank of Montreal reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Bank of Montreal sold 74,100 Orexigen Therapeutics, Inc. shares in Q1 2018, an estimated $95K.
Bank of Montreal first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 12 quarters.
Bank of Montreal's Orexigen Therapeutics, Inc. position peaked at $304K in Q1 2017.
27 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2018.

Based on Bank of Montreal's 13F filing for Q1 2018, filed 13 Apr 2018.